510(k) Report

510(k) · Cleared

Cleared

Careside Alt

K020487510(k) TraditionalCleared Jun 4, 2002111-day reviewClass I21 CFR 862.1030

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Careside, Inc. · CKA Nadh Oxidation/Nad Reduction, Alt/Sgpt

Cleared on Jun 4, 2002 as substantially equivalent to K912844 (Eastman Kodak Company, 1991) after a 111-day review. Its family tree reaches back 1 generation to 1991.

Decided
Jun 4, 2002
Review
111 days
Class
Class I
Product code
CKA
Recalls
None
Predicates
1

Its longest line of descent runs back 1 generation to K912844 (1991). No later device cites it as a predicate yet.

K912844 · Kodak Ektachem Dtii System · Eastman Kodak Company · 199119901992199419961998200020022004
K912844 · Kodak Ektachem Dtii System · Eastman Kodak Company · 19910
  1. Root · 1 generation backK912844 Kodak Ektachem Dtii SystemEastman Kodak Company · 1991
  2. This deviceK020487 Careside AltCareside, Inc. · 2002
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−1K912844Kodak Ektachem Dtii SystemEastman Kodak Company1991—
0 (this device)K020487Careside AltCareside, Inc.2002—
FIG. 1 — Lineage of K020487, 1991–2002Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in CKA? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

  • Candidate predicates for a device like this, rankedin the report
  • Recall history across each candidate’s familyin the report
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K912844Kodak Ektachem Dtii System
Summary page 2
…LT Premarket Notification Page 11 April 30,2002 Predicate Device 5 10K number: K9 12844lA Product Code: 75cKA IV. Device Description CARESIDE ALT cartridges are used wit…
Eastman Kodak Company1991—

Also cleared against K912844: 28 other devices →

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • Its one ancestor has no recall.
  • 28 other devices also cite its predicate K912844.

How does its category compare?

All CKA devices

CKA Nadh Oxidation/Nad Reduction, Alt/Sgpt: FDA decisions, review times, recalls and adverse event reports over 20 years.

FDA decisions per year · CKA

1in 2013

2012: 12013: 1
2007high 1 (2012) · low 0 (2007)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · CKA

Too few CKA 510(k)s in any year since 2007 to give a median.

Recalls per year · CKA

1in 2016

2007: 82010: 12016: 1
2007high 8 (2007) · low 0 (2008)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · CKA

8in 2025

2010: 82011: 392012: 82017: 22018: 12020: 32021: 22022: 22023: 42024: 102025: 8
2007high 39 (2011) · low 0 (2007)2025

MAUDE reports naming product code CKA, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20070—80
20080—00
20090—00
20100—18
20110—039
20121—08
20131—00
20140—00
20150—00
20160—10
20170—02
20180—01
20190—00
20200—03
20210—02
20220—02
20230—04
20240—010
20250—08
20260—0—

What is it indicated for?

For in vitro diagnostic use with the CARESIDE Analyzer to quantitatively measure ALT from anti-coagulated whole blood, plasma, or serum specimens to aid in the diagnosis and treatment of patients with certain types of liver and heart disease

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K020487: Careside Alt.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K020487

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026